PYC Therapeutics (ASX:PYC) appoints Doug Huey as CEO to establish Boston office
- Biotech company PYC Therapeutics (PYC) has appointed Douglas Huey as CEO and Board Director
- The current CEO, Rohan Hockings, will step down but will remain a Board Director and Chief Strategy Officer
- Doug has been entrusted to establish a U.S. office based in Boston as the company expands their pipeline
PYC Therapeutics (ASX:PYC) appoints Doug Huey as CEO to...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.27 |
Change
-0.055(4.15%) |
Mkt cap ! $740.7M | |||
| Open | High | Low | Value | Volume |
| $1.30 | $1.32 | $1.24 | $3.867M | 3.068M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 14485 | $1.27 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.29 | 5019 | 8 |
View Market Depth
| Last trade - 15.01pm 11/08/2025 (20 minute delay) ? |
| PYC (ASX) Chart |